Growth Metrics

Invivyd (IVVD) Accounts Payables (2020 - 2025)

Invivyd posted quarterly Accounts Payables of $13.7 million for Q4 2025, up 31.55% year-on-year from $10.4 million in Q4 2024, and down 24.08% on a QoQ basis from $18.1 million in Q3 2025.

Invivyd (IVVD) has 6 years of Accounts Payables data on file, last reported at $13.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 31.55% year-over-year to $13.7 million; the trailing twelve-month figure through Dec 2025 stood at $13.7 million (up 31.55% YoY), and the FY2025 full-year result was $13.7 million, up 31.55% from the prior year.
  • Accounts Payables for Q4 2025 stood at $13.7 million, down from $18.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $18.7 million in Q1 2022 and bottomed at $1.2 million in Q1 2024.
  • The 5-year median for Accounts Payables is $10.4 million (2024), against an average of $10.9 million.
  • The widest annual swing landed in 2024, when Accounts Payables slumped 80.25%; it then jumped 648.2% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $5.8 million in 2021, then plunged by 73.77% to $1.5 million in 2022, then jumped by 424.26% to $8.0 million in 2023, then surged by 31.37% to $10.4 million in 2024, then jumped by 31.55% to $13.7 million in 2025.
  • The last three Accounts Payables figures came in at $13.7 million (Q4 2025), $18.1 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 13.74 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 13.74 Mn
Sep 30, 2025 18.10 Mn
Jun 30, 2025 18.05 Mn
Mar 31, 2025 8.74 Mn
Dec 31, 2024 10.45 Mn
Sep 30, 2024 17.71 Mn
Jun 30, 2024 7.50 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 7.95 Mn
Sep 30, 2023 9.17 Mn
Jun 30, 2023 4.11 Mn
Mar 31, 2023 5.91 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 16.77 Mn
Jun 30, 2022 14.23 Mn
Mar 31, 2022 18.68 Mn
Dec 31, 2021 5.78 Mn
Sep 30, 2021 17.56 Mn
Jun 30, 2021 10.72 Mn
Dec 31, 2020 8.15 Mn